{
  "ptid_time": "024_S_1400_2007-05-08",
  "img_path": "/data/qiuhui/data/adni/images/024_S_1400/2007-05-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 27,506 mm³, 28.6% below the reference mean. With a Z-score of -0.68 (24.7th percentile), this represents normal volume ; hippocampal volume measures 6,261 mm³, 17.2% below the reference mean. With a Z-score of -1.68 (4.7th percentile), this represents moderate atrophy; whole brain volume measures 954,575 mm³, 11.6% below the reference mean. With a Z-score of -1.50 (6.7th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,585 mm³, 37.0% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,764 mm³, 26.9% below the reference mean. With a Z-score of -2.29 (1.1th percentile), this represents significant atrophy; middle temporal gyrus volume measures 17,736 mm³, 16.9% below the reference mean. With a Z-score of -1.52 (6.5th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 77.9 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Malignancy. MMSE: 25.0. Logical Memory: 3.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex and fusiform gyrus, along with moderate atrophy in the hippocampus, whole brain, and middle temporal gyrus—all regions heavily implicated in Alzheimer's disease. The MMSE score of 25 is borderline but aligns with early cognitive decline, while the absence of APOE4 does not rule out AD given the structural findings.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to underlying Alzheimer’s pathology).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but MCI diagnosis relies on clinical correlation; lack of APOE4 and MMSE just above the typical MCI cutoff introduce some uncertainty).  \n\n*Note:* If longitudinal decline or biomarker evidence (e.g., amyloid PET, CSF) supports progression, this would upgrade confidence toward **Alzheimer’s dementia**.",
  "timestamp": "2025-07-26T03:15:44.611260"
}